BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 8522958)

  • 21. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
    Watts VJ; Neve KA
    Mol Pharmacol; 1996 Oct; 50(4):966-76. PubMed ID: 8863843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasoactive intestinal peptide is a secretagogue in bovine chromaffin cells pretreated with pertussis toxin.
    Wilson SP
    Neuropeptides; 1992 Nov; 23(3):187-92. PubMed ID: 1335135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal dopamine D1 and D2 receptors: characterization by binding or pharmacological studies and physiological functions.
    Schorderet M; Nowak JZ
    Cell Mol Neurobiol; 1990 Sep; 10(3):303-25. PubMed ID: 2174740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acid stress induces a D1-like dopamine receptor in pituitary MSH cells of Oreochromis mossambicus.
    Lamers AE; Ter Brugge PJ; Flik G; Wendelaar Bonga SE
    Am J Physiol; 1997 Jul; 273(1 Pt 2):R387-92. PubMed ID: 9249576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus.
    Zhao Y; Kerscher N; Eysel U; Funke K
    J Physiol; 2002 Feb; 539(Pt 1):223-38. PubMed ID: 11850515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
    Ruskin DN; Rawji SS; Walters JR
    J Pharmacol Exp Ther; 1998 Jul; 286(1):272-81. PubMed ID: 9655869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
    Onali P; Olianas MC
    Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
    Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE
    Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement.
    Calabresi P; Mercuri N; Stanzione P; Stefani A; Bernardi G
    Neuroscience; 1987 Mar; 20(3):757-71. PubMed ID: 2955246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
    Barton AC; Black LE; Sibley DR
    Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D2 dopamine receptors modulate calcium channel currents and catecholamine secretion in bovine adrenal chromaffin cells.
    Bigornia L; Allen CN; Jan CR; Lyon RA; Titeler M; Schneider AS
    J Pharmacol Exp Ther; 1990 Feb; 252(2):586-92. PubMed ID: 2156054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
    Cho S; Neff NH; Hadjiconstantinou M
    Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation.
    Harvey J; Lacey MG
    J Physiol; 1996 Apr; 492 ( Pt 1)(Pt 1):143-54. PubMed ID: 8730590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine receptor subtypes colocalize in rat striatonigral neurons.
    Surmeier DJ; Eberwine J; Wilson CJ; Cao Y; Stefani A; Kitai ST
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10178-82. PubMed ID: 1332033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic 3',5'-adenosine monophosphate mediates dopamine D1-stimulated growth hormone release from goldfish pituitary cells.
    Wong AO; van der Kraak G; Chang JP
    Neuroendocrinology; 1994 Oct; 60(4):410-7. PubMed ID: 7529899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.